The company

Ipsen Group
Ipsen is a global specialty-driven pharmaceutical company and also has a significant presence in consumer healthcare. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in 30 countries worldwide. The Group has more than 4,900 employees worldwide.

An international group
Ipsen is a global specialty-driven pharmaceutical company and also has a significant presence in consumer healthcare. Our ambition is to become a leader in the treatment of targeted debilitating diseases.

Our areas of expertise include oncology, neurosciences, endocrinology (adult and child) and gastroenterology. Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at improving the lives of patients with neuroendocrine tumors, prostate, bladder and kidney cancer.

Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in 30 countries worldwide. The Group employs more than 4,600 people worldwide and recorded sales in excess of €1.4 billion in 2015.

Our strategy
Ipsen’s strategy is based on a focus on niche therapeutic areas in specialty care and on gastroenterology in consumer healthcare.

Specialty care:
o A focus on three niche therapeutic areas where Ipsen has the potential to become a leader: neuroendocrine tumors, spasticity and aesthetic medicine;
o Ipsen continues to strengthen its presence in its historical therapeutic specialty areas: uro-oncology and endocrinology
o At the same time, we are pursuing advancements in connected therapeutic areas, specifically gastrointestinal and orphan cancers.

Consumer healthcare:
o Ipsen aims to optimize its gastroenterology portfolio while diversifying into complementary products;
o The Group is expanding its geographical footprint and developing a dual Rx/OTC commercial model to build on its strong brand recognition.

Research and Development
Ipsen’s R&D activities are focused on the discovery and development of new molecules and on programs to manage the lifecycle of our existing products.
Focused on peptides and toxins, our R&D teams are constantly deepening and adding to the expertise of these two platforms. Our goal is to improve understanding of both the basic science and clinical aspects of peptides and toxins. Ipsen has entered into agreements with highly specialized companies in these fields and is strengthening its partnership policy through agreements with major research institutes and medical centers of excellence, on a global scale.
Ipsen has three R&D centers located at the heart of three internationally renowned science hubs: Paris-Saclay in France, Oxford in the United Kingdom, and Cambridge in the United States. In close contact with leading academic research centers, cutting-edge medical centers and biotechnological companies, Ipsen has an active partnership policy based on open innovation.

For further information about Ipsen, please visit http://www.ipsen.com and http://www.ipsennordic.com

Ipsen Nordics
In the Nordic countries, we are represented since 2006 with a Nordic office in Kista Science Tower outside Stockholm.

In Norway, Denmark and Finland, we have locally based product specialists. Today we are 45 employees in the Nordic region who work with clinical research, marketing and sales of our products. We work mainly in the therapeutic areas of endocrinology, oncology and neuromuscular diseases.

The Nordic organisation consist of a broad-based mixture of functions and specialists such as Medical, Sales, Marketing, Market Access, Tender Management, Regulatory Affairs, Supply chain, General management, Finance and others. The majority of resources are shared within the Nordics and others are primarily local resources.

The Medical department Nordic has 10 employees with primary focus on Medical affairs, Drug safety and Clinical research. This in the prioritized therapeutic areas; oncology, neurosciences, endocrinology (adult and child) and gastroenterology.

All the diversity and the overall specialist competencies in the organisation creates a solid environment for a fruitful collaboration, both in the Nordic as well as locally.

Ipsen Nordics has attained a good position and a positive development with substantial growth over the years.

About Neurosciences
Neuroscience is the study of the central nervous system, which may be responsible for very disabling movement disorders that impact negatively on patients’ quality of life and independence.

Blepharosmasm
Blepharospasm causes involuntary contractions of the muscles of the eyelids. The disorder can also lead to uncontrollable blinking and in some cases, sufferers may be unable to open their eyes, which reduces their ability to carry out everyday activities. Learn more about the condition, its diagnosis and the different treatment options available.

Cerebral palsy
Cerebral palsy is the term used to describe various movement disorders caused by damage to the brain during pregnancy, birth or in infancy. Sufferers may also have cognitive impairment, delayed mental development and pain that have serious negative consequences for their quality of life and independence. Learn more about the condition, its diagnosis and the different treatment options available.

Cervical dystonia
Cervical dystonia, also referred to as spasmodic torticollis, is a condition with intermittent or continuous painful spasms of the muscles of the neck – and sometimes the shoulder – that cause an abnormal posture of the head. This neurological movement disorder gets gradually worse and the symptoms can also include jerking movements of the head, neck pain, and a raised shoulder. Learn more about this condition, its diagnosis and the different treatment options available.

Equinus deformity
Equinus or spastic equinovarus is a foot deformity that most commonly occurs secondary to cerebral stroke (CVA) or cerebral palsy but may also be a congenital deformity. The pathology causes gait abnormality in patients and is a very real handicap when it comes to mobility. Learn more about the condition, its diagnosis and the different treatment options available.

Hemifacial spasm
Hemifacial spasm is an involuntary contraction (spasm) of the muscles on one side of the face. This chronic constricting condition can become almost permanent over time and evolve into a disabling disfigurement and social embarrassment. Learn more about the condition, its diagnosis and the different treatment options available.

Hyperhidrosis
Hyperhidrosis, or hyper perspiration, is excessive sweating beyond what is needed to regulate body temperature. The areas generally affected by the condition are the armpits, hands, feet and face, but hyperhidrosis may also spread to the entire body. Learn more about the condition, its diagnosis and the different treatment options available.

Spasticity
A number of pathologies can be responsible for spasticity, including cerebral stroke (CAV), head trauma, multiple sclerosis, cerebral palsy, and others. Constantly contracted, the spastic limbs loose flexibility, causing pain and mobility problems for sufferers. Ipsen has a long history of developing treatment for spasticity. Learn the characteristics and causes of the condition, methods of diagnosis and the various treatment options available.

Dysport® (Clostridium botulinum toxin type A haemagglutinin complex)

Indications

Dysport is indicated for symptomatic treatment of focal spasticity of:
- Upper limbs in adults
- Lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (TBI)
- Dynamic equinus foot deformity in ambulant pediatric cerebral palsy patients, two years of age or older.

Dysport is indicated in adults for symptomatic treatment of:
- Spasmodic torticollis
- Blepharospasm
- Hemifacial spasm
- Severe primary hyperhidrosis of the axillae, which does not respond to topical treatment with antiperspirants or antihidrotics.

For more information about Dysport, please visit http://www.ipsennordic.com.

 

Key Account Manager Neuroscience, Ipsen

Spännande affärsutvecklingsuppdrag för duktig Key Account Manager

The position Key Account Manager mid/north Sweden Neuroscience

Position: Key Account Manager mid/north Sweden Neuroscience (KAM)

Supervisor: Business Unit Director Neuroscience and Rare disease

Location: mid Sweden (Stockholm, Uppsala, Mälardalen, Södermanland, Närke, Västmanland, Östergötland)

Ipsen Nordic headquarters: Kista Science Tower, Kista outside Stockholm

Introduction and background Ipsen Neuroscience
Undertreatment of patients with spasticity and hyperhidrosis is an opportunity in the market

Ipsen has a solid platform and an impressive development within Neuroscience. Dysport is an established and well documented treatment for several Neuroscience indications. Dysport have had a very good sales development in the region mid/north Sweden over the years.

Even though there has been an increase in the number of treated patients over time there are still many patients with spasticity and hyperhidrosis that do not get the treatment with Dysport.

Ipsen is actively addressing these opportunities long term and is adding value to patients and healthcare through educational programmes and clinical projects within Neuroscience.

The Key Account Manager is one of the key drivers for the development of the market. There is a solid platform for Dysport with specific product benefits as well as value adding projects and activities for patients and healthcare.

Purpose of the position
The KAM is a member of the Business Unit Neuroscience and Rare disease. He/she is a field-based professional with sales, business development, clinical and therapeutic area expertise who is responsible for the sales and business development in the region mid/north Sweden. The KAM is managing the regional business to reach the objectives for the region. The KAM works with support and in collaboration with the colleagues, management and specialists within Neuroscience in Ipsen Nordic (Business Unit Director, KAM colleagues, Medical Advisor, Market Access, Nordic Medical Scientific Liaison and others). He/she develops the regional plan with a clear focus on sales and developing the market initiating and accomplishing specific activities and projects with key stakeholders and other valid partners within the healthcare community.

Opportunities with the role

• Having the opportunity to develop and grow the market for Dysport by tailoring specific projects and activities in the region
• To represent Ipsen, a family owned growing global pharmaceutical company with a focus on R&D and a strong commitment to improve life for patients within Endocrinology, Oncology, Neuroscience and Rare Diseases
• Work in an innovative, expansive and dynamic company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses
• Having the opportunity to work with Dysport a state of the art treatment for patient with different Neuroscientific diagnosis
• Be part of a Nordic team, with deep knowledge, highly motivated, and with a good cooperation and positive atmosphere
• Ipsen has an attractive company culture with excellent opportunities for professional and personal development (for instance very good opportunities for internal job rotation).

Experience, qualifications and competencies
We are looking for a successful sale- and business developer with the ability to develop the market potential to a regional plan with specific activities and projects with focus on growth and treatment development.

The successful Key Account Manager candidate will be experienced in successful sales- and customer operations within healthcare. Some market access experience will be an advantage. She/he will previously have held a similar role or other relevant sales- or customer facing roles and will have an ability and desire to work across the broad span of hands-on work, but also add to the strategy and regional planning.

The person will be self-motivated and at times work autonomously to consistently deliver operational excellence in all activities.

The successful candidate for the position will be a recognized sales profile with a proven track-record of effective cross-functional collaboration.

Education qualifications:
• Degree level, ideally science/medicine/pharmacy or business

Certifications:
• Qualifying Educational degree or Completed relevant local certification to work with pharmaceutical product in market (Medicinsk Grundutbildning (MGU) or exemption)
• Clean and valid Drivers license

Learning Experience / Work Experience
• Solid experience and a solid track record from a commercial sales role within healthcare
• Experienced in developing, managing and maintaining relationships with key prescribers and support healthcare professionals (HCPs)
• Experience from Market access and managing different regional stakeholders is an advantage
• Understanding of the current local code of conduct
• Experience in the Neurology area or in other related therapeutic are is an advantage

Languages
• Fluency in spoken and written Swedish. Good knowledge in English.

Systems
• Experienced user in MS Office

Personal Attributes
• Strategic and creative with relation to business development and business development opportunities and initiatives
• Well-developed communication-, presentation- and negotiation skills
• High level of self-leadership, time management and to prioritize
• Social and outgoing personality with a solid ability for people contact, relations and networking
• Prepared for significant travel and customer contacts.

Location
• In the region, preferable mid Sweden

Contact
For inquires and more information about the Key Account Manager Neuroscience position, please contact Magnus Klingberg, Senior Recruitment Consultant or Jenny Ringh, Senior Recruitment Consultant at PeakSearch.
Apply for the position at http://www.peaksearch.se.

Contact details
Magnus Klingberg
e-mail: magnus.klingberg@peaksearch.se
mobile: +46 (0)70-678 09 92 office telephone: +46 (0)8-545 00 100

Jenny Ringh
Email: jenny@peaksearch.se
Mobile: +46-(0)70-235 81 99, telephone: +46-(0)8-545 00 100
web: http://www.peaksearch.se